Contact Us
Drug Search Results
More Filters [+]

CPG-10101

Alternative Names: cpg-10101, cpg10101, cpg 10101, actilon
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

CPG 10101 (ACTILON) is a novel potent and selective unmethylated cytidine-phosphate-guanosine (CpG)-containing oligodeoxynucleotide agonist of Toll-like receptor 9 (TLR9) being developed for the treatment of chronic infections such as HCV.

Mechanisms of Action: TLR9 Agonist

Novel Mechanism: Yes

Modality: N/A

Route of Administration: Oral,Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CPG-10101

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatitis C, Chronic|Hepatitis A

Phase 1: Hepatitis A|Hepatitis C, Chronic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
B1211002

P2

Completed

Hepatitis A|Hepatitis C, Chronic

2007-07-01

B1211001

P1

Completed

Hepatitis A|Hepatitis C, Chronic

2007-02-01

Recent News Events

Date

Type

Title

05/15/2024

PubMed

 Bioselective and Radiopaque Zinc-Biopolymeric Complex-Based Porous Biomaterials Promote Mammalian Tissue Ingrowth In Vivo While Inhibiting Microbial Biofilm Gene Expression and Biofilm Formation.

05/15/2024

PubMed

 Insight into the Relationship Between Motor and Cognitive Symptoms in Essential Tremor.

05/15/2024

PubMed

 Does an Aspirin a Day Take the MASLD Away?

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions